Clinical Trials
Human RCT
Conservative kidney care matched dialysis on quality-adjusted life in frail older adults
Source: The Lancet
Prepare for Kidney Care was a pragmatic phase 3 randomized trial in 31 kidney centres across England, Wales, Scotland and Northern Ireland. It enrolled people with an eGFR below 15 who were aged 80 or older, or aged 65 to 79 with frailty or multimorbidity. Participants were assigned to prepare for responsive management (focused on slowing progression, managing symptoms and preserving quality of life without dialysis) or to prepare for dialysis.
What they found
Of 6,120 people screened, 445 were randomized. Over a mean follow-up of 4.5 years, mean quality-adjusted life-years were 1.354 in the conservative care group and 1.472 in the dialysis-preparation group (adjusted difference -0.147, 95% CI -0.350 to 0.056, p=0.16). Dialysis access complications were lower with conservative care (adjusted rate ratio 0.41), and hospital admission rates were similar.
The nuance
The trial found no evidence that either path was superior, which is not the same as proving they are equal. Deaths were 69% in the conservative care group and 63% in the dialysis-preparation group. The trial was open label, and only 7% of screened patients enrolled, so results apply to people similar to those who took part.
Youthful take
For older adults facing kidney failure, the right choice depends on personal goals, function and values. This trial supports a shared decision with your nephrology team rather than a default in either direction.
Primary source
Caskey FJ, Worthington J, Liu Y, et al. Preparing for responsive management versus renal dialysis in older people living with kidney failure and frailty or multimorbidity in the UK (Prepare for Kidney Care): a phase 3 randomised controlled trial. Lancet, 2026. doi:10.1016/S0140-6736(26)01818-0 (PMID 42982076)
More from the research desk
Brain & Cognition
NAD+ booster nicotinamide riboside did not help early Parkinson’s disease in a year-long phase 3 trial
Clinical Trials
Daily low-dose aspirin did not protect function in 18,581 older adults, and women declined slightly faster
Exercise & Muscle